Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.

C. Belloni, P. Orsolini, L. Soldini, D. Campisi, A. Chiesa, R. Ciceri, G. Filice

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A group of 43 healthy neonates born from HBsAg-positive mothers were evaluated for the presence of protective HBsAb titre after administration of hepatitis B plasma-derived vaccine and hepatitis B hyperimmune-globulin. At 36 months of life we found that a significant number of children had a low HBsAb serum level. This suggests that a close serologic follow-up is necessary to evaluate the optimal timing for the administration of a booster dose of the vaccine.

Original languageEnglish
Pages (from-to)195-198
Number of pages4
JournalMicrobiologica
Volume14
Issue number3
Publication statusPublished - Jul 1991

Fingerprint

Hepatitis B Vaccines
Hepatitis B Surface Antigens
Vaccines
Mothers
Newborn Infant
Hepatitis B
Serum
hepatitis B hyperimmune globulin

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology

Cite this

Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers. / Belloni, C.; Orsolini, P.; Soldini, L.; Campisi, D.; Chiesa, A.; Ciceri, R.; Filice, G.

In: Microbiologica, Vol. 14, No. 3, 07.1991, p. 195-198.

Research output: Contribution to journalArticle

Belloni, C, Orsolini, P, Soldini, L, Campisi, D, Chiesa, A, Ciceri, R & Filice, G 1991, 'Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.', Microbiologica, vol. 14, no. 3, pp. 195-198.
Belloni, C. ; Orsolini, P. ; Soldini, L. ; Campisi, D. ; Chiesa, A. ; Ciceri, R. ; Filice, G. / Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers. In: Microbiologica. 1991 ; Vol. 14, No. 3. pp. 195-198.
@article{858b1643ff97465f8604cffba06f719f,
title = "Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.",
abstract = "A group of 43 healthy neonates born from HBsAg-positive mothers were evaluated for the presence of protective HBsAb titre after administration of hepatitis B plasma-derived vaccine and hepatitis B hyperimmune-globulin. At 36 months of life we found that a significant number of children had a low HBsAb serum level. This suggests that a close serologic follow-up is necessary to evaluate the optimal timing for the administration of a booster dose of the vaccine.",
author = "C. Belloni and P. Orsolini and L. Soldini and D. Campisi and A. Chiesa and R. Ciceri and G. Filice",
year = "1991",
month = "7",
language = "English",
volume = "14",
pages = "195--198",
journal = "Microbiologica",
issn = "0391-5352",
publisher = "Luigi Ponzio e figlio Editori",
number = "3",

}

TY - JOUR

T1 - Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers.

AU - Belloni, C.

AU - Orsolini, P.

AU - Soldini, L.

AU - Campisi, D.

AU - Chiesa, A.

AU - Ciceri, R.

AU - Filice, G.

PY - 1991/7

Y1 - 1991/7

N2 - A group of 43 healthy neonates born from HBsAg-positive mothers were evaluated for the presence of protective HBsAb titre after administration of hepatitis B plasma-derived vaccine and hepatitis B hyperimmune-globulin. At 36 months of life we found that a significant number of children had a low HBsAb serum level. This suggests that a close serologic follow-up is necessary to evaluate the optimal timing for the administration of a booster dose of the vaccine.

AB - A group of 43 healthy neonates born from HBsAg-positive mothers were evaluated for the presence of protective HBsAb titre after administration of hepatitis B plasma-derived vaccine and hepatitis B hyperimmune-globulin. At 36 months of life we found that a significant number of children had a low HBsAb serum level. This suggests that a close serologic follow-up is necessary to evaluate the optimal timing for the administration of a booster dose of the vaccine.

UR - http://www.scopus.com/inward/record.url?scp=0026197120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026197120&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 195

EP - 198

JO - Microbiologica

JF - Microbiologica

SN - 0391-5352

IS - 3

ER -